Have your own idea? Try our Stock Screener
Israeli (TA) Biotech Industry Analysis
UpdatedMar 09, 2026
DataAggregated Company Financials
Companies11
- 7D2.0%
- 3M22.6%
- 1Y11.5%
- YTDn/a
In the last week, the Biotech industry is up 2.0%, with Kamada up 2.9%. Meanwhile, Evogene actually underperformed within the industry, shrinking 8.2% in the last week. This takes the industry's 12 month performance to a gain of 12%. As for the next few years, earnings are expected to grow by 15% per annum.
Industry Valuation and Performance
Has the Israeli Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 09 Mar 2026 | ₪2.6b | ₪605.5m | -₪60,105,382.20 | 15.6x | -43.8x | 4.3x |
| Wed, 04 Feb 2026 | ₪2.5b | ₪605.0m | -₪60,100,135.40 | 14.3x | -41.8x | 4.1x |
| Fri, 02 Jan 2026 | ₪2.2b | ₪628.0m | -₪63,195,366.00 | 12.4x | -34.4x | 3.5x |
| Sun, 30 Nov 2025 | ₪2.1b | ₪644.1m | -₪66,695,267.50 | 12.1x | -31.2x | 3.2x |
| Tue, 28 Oct 2025 | ₪2.1b | ₪645.4m | -₪93,991,510.00 | 13.4x | -22.8x | 3.3x |
| Thu, 25 Sep 2025 | ₪2.1b | ₪662.5m | -₪99,860,426.00 | 12.7x | -21.2x | 3.2x |
| Sat, 23 Aug 2025 | ₪2.2b | ₪669.6m | -₪133,066,649.70 | 13.3x | -16.2x | 3.2x |
| Mon, 21 Jul 2025 | ₪2.2b | ₪667.9m | -₪128,669,789.40 | 16x | -17.5x | 3.4x |
| Wed, 18 Jun 2025 | ₪2.2b | ₪695.9m | -₪130,292,679.50 | 15.4x | -16.9x | 3.2x |
| Fri, 16 May 2025 | ₪2.2b | ₪735.8m | -₪156,114,532.00 | 14.8x | -14.2x | 3x |
| Sun, 13 Apr 2025 | ₪2.0b | ₪750.2m | -₪163,015,976.20 | 14.6x | -12.5x | 2.7x |
| Tue, 11 Mar 2025 | ₪2.2b | ₪704.8m | -₪224,911,667.20 | 17x | -9.9x | 3.2x |
| Thu, 06 Feb 2025 | ₪2.1b | ₪673.1m | -₪226,287,746.60 | 15.6x | -9.5x | 3.2x |
| Sat, 04 Jan 2025 | ₪2.1b | ₪692.6m | -₪230,010,784.60 | 14.4x | -9x | 3x |
| Mon, 02 Dec 2024 | ₪2.0b | ₪689.4m | -₪226,700,012.40 | 13.5x | -8.7x | 2.9x |
| Wed, 30 Oct 2024 | ₪2.0b | ₪682.4m | -₪256,951,136.90 | 13.5x | -7.8x | 2.9x |
| Fri, 27 Sep 2024 | ₪2.1b | ₪677.6m | -₪255,803,502.20 | 13.2x | -8.1x | 3x |
| Sun, 25 Aug 2024 | ₪2.2b | ₪674.4m | -₪217,624,503.00 | 13.5x | -10x | 3.2x |
| Tue, 23 Jul 2024 | ₪2.2b | ₪627.1m | -₪324,418,360.90 | 17.2x | -6.8x | 3.5x |
| Thu, 20 Jun 2024 | ₪2.0b | ₪641.5m | -₪329,963,658.30 | 15.5x | -6.1x | 3.2x |
| Sat, 18 May 2024 | ₪2.1b | ₪598.9m | -₪382,053,327.70 | 16.4x | -5.5x | 3.5x |
| Mon, 15 Apr 2024 | ₪2.1b | ₪619.2m | -₪408,208,581.40 | 21.2x | -5.1x | 3.4x |
| Wed, 13 Mar 2024 | ₪2.3b | ₪549.1m | -₪371,170,374.00 | 54.2x | -6.3x | 4.3x |
| Fri, 09 Feb 2024 | ₪2.3b | ₪586.9m | -₪367,987,999.40 | 62.2x | -6.3x | 3.9x |
| Sun, 07 Jan 2024 | ₪2.4b | ₪629.5m | -₪399,551,706.00 | 62.8x | -6.1x | 3.9x |
| Tue, 05 Dec 2023 | ₪2.1b | ₪637.0m | -₪404,461,308.00 | 57x | -5.3x | 3.3x |
| Thu, 02 Nov 2023 | ₪2.1b | ₪646.2m | -₪426,135,624.00 | 72.3x | -4.9x | 3.2x |
| Sat, 30 Sep 2023 | ₪2.3b | ₪619.8m | -₪409,216,995.00 | 76x | -5.6x | 3.7x |
| Mon, 28 Aug 2023 | ₪1.9b | ₪615.4m | -₪339,240,215.00 | 65.3x | -5.6x | 3.1x |
| Wed, 26 Jul 2023 | ₪1.9b | ₪551.0m | -₪396,904,193.00 | n/a | -4.8x | 3.4x |
| Fri, 23 Jun 2023 | ₪1.9b | ₪538.6m | -₪390,277,976.00 | n/a | -4.9x | 3.6x |
| Sun, 21 May 2023 | ₪1.8b | ₪529.4m | -₪371,506,126.00 | n/a | -4.8x | 3.3x |
| Tue, 18 Apr 2023 | ₪1.7b | ₪607.2m | -₪443,466,292.00 | n/a | -3.8x | 2.8x |
| Thu, 16 Mar 2023 | ₪1.5b | ₪560.0m | -₪462,637,201.00 | 4.3x | -3.3x | 2.7x |
Price to Earnings Ratio
-3.3x
Current Industry PE
- Investors are optimistic on the Israeli Biotechnology industry, and appear confident in long term growth rates.
- The 3-year average PS ratio of 3.4x is lower than the industry's current PS ratio of 4.3x.
Past Earnings Growth
- The earnings for companies in the Biotechnology industry have improved over the last three years.
- Revenues for these companies have grown 2.6% per year.
- This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.
Industry Comparison
How does Israeli Biotech compare with similar industries?
| IL Market | 8.23% | |
| Healthcare | 3.95% | |
| Biotech | 1.98% | |
| Biotech | 1.98% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| XTLB XTL Biopharmaceuticals | ₪0.022 | 10.0% +₪1.9m | -55.1% | PS6.9x | |
| GRAC Grace Breeding | ₪17.56 | 0.2% +₪125.4k | 2.5% | PB40.9x | |
| MTLF Matricelf | ₪4.95 | 0.06% +₪87.7k | 43.5% | PB17.5x |